Chlora-cleanze
NDC Package 71389-001-03
Package Information
Chlora-cleanze is use prior to surgery to prepare patient’s skin. Marketed by Biotronix Healthcare Industries, Inc., this product is identified by NDC 71389-001 and is authorized under FDA application part333A.
Identification & Billing
- RxCUI: 1918214 - chlorhexidine gluconate 2 % / isopropyl alcohol 70 % Medicated Pad
- RxCUI: 1918214 - chlorhexidine gluconate 20 MG/ML / isopropyl alcohol 0.7 ML/ML Medicated Pad
- RxCUI: 1918214 - chlorhexidine gluconate 2 % / isopropyl alcohol 70 % Topical Swab
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71389 - Biotronix Healthcare Industries, Inc.
- 71389-001 - Chlora-cleanze
- 71389-001-03 - 1.75 mL in 1 POUCH
- 71389-001 - Chlora-cleanze
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71389-001). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71389-001-03 identifies a specific commercial package of 1.75 ml in 1 pouch of Chlora-cleanze, labeled by Biotronix Healthcare Industries, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Biotronix Healthcare Industries, Inc. on April 18, 2017. The current certification is valid through December 31, 2021.
How is this Biotronix Healthcare Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71389000103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.